commercial protein bar
Selected indexed studies
- Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis. (JAMA Neurol, 2024) [PMID:38466277]
- Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners Foundation. (Ann Oncol, 2024) [PMID:38648979]
- Characterizing molecular and synaptic signatures in mouse models of late-onset Alzheimer's disease independent of amyloid and tau pathology. (Alzheimers Dement, 2024) [PMID:38735056]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis. (2024) pubmed
- Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners Foundation. (2024) pubmed
- Characterizing molecular and synaptic signatures in mouse models of late-onset Alzheimer's disease independent of amyloid and tau pathology. (2024) pubmed
- Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma. (2025) pubmed
- Dupilumab shows no elevated risk for maternal adverse pregnancy outcomes: A propensity-matched cohort study. (2025) pubmed
- Hexokinase2-engineered T cells display increased anti-tumor function. (2025) pubmed
- Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies. (2025) pubmed
- High-Protein Bar as a Meal Replacement in Elite Sports Nutrition: A Pilot Study. (2021) pubmed
- Revisiting I-BAR Proteins at Central Synapses. (2021) pubmed
- Role of sweeteners on temporality and bar hardening of protein bars. (2020) pubmed